Continuous 24-h Photoplethysmogram Monitoring Enables Detection of Atrial Fibrillation
- PMID: 35058796
- PMCID: PMC8764282
- DOI: 10.3389/fphys.2021.778775
Continuous 24-h Photoplethysmogram Monitoring Enables Detection of Atrial Fibrillation
Abstract
Aim: Atrial fibrillation (AF) detection is challenging because it is often asymptomatic and paroxysmal. We evaluated continuous photoplethysmogram (PPG) for signal quality and detection of AF. Methods: PPGs were recorded using a wrist-band device in 173 patients (76 AF, 97 sinus rhythm, SR) for 24 h. Simultaneously recorded 3-lead ambulatory ECG served as control. The recordings were split into 10-, 20-, 30-, and 60-min time-frames. The sensitivity, specificity, and F1-score of AF detection were evaluated for each time-frame. AF alarms were generated to simulate continuous AF monitoring. Sensitivities, specificities, and positive predictive values (PPVs) of the alarms were evaluated. User experiences of PPG and ECG recordings were assessed. The study was registered in the Clinical Trials database (NCT03507335). Results: The quality of PPG signal was better during night-time than in daytime (67.3 ± 22.4% vs. 30.5 ± 19.4%, p < 0.001). The 30-min time-frame yielded the highest F1-score (0.9536), identifying AF correctly in 72/76 AF patients (sensitivity 94.7%), only 3/97 SR patients receiving a false AF diagnosis (specificity 96.9%). The sensitivity and PPV of the simulated AF alarms were 78.2 and 97.2% at night, and 49.3 and 97.0% during the daytime. 82% of patients were willing to use the device at home. Conclusion: PPG wrist-band provided reliable AF identification both during daytime and night-time. The PPG data's quality was better at night. The positive user experience suggests that wearable PPG devices could be feasible for continuous rhythm monitoring.
Keywords: algorithms; atrial fibrillation; monitoring; photoplethysmogram; photoplethysmography; quality; screening; signal quality analysis.
Copyright © 2022 Väliaho, Lipponen, Kuoppa, Martikainen, Jäntti, Rissanen, Castrén, Halonen, Tarvainen, Laitinen, Laitinen, Santala, Rantula, Naukkarinen and Hartikainen.
Conflict of interest statement
JL, TR, TM, HJ, JH, and MT are shareholders of a company (Heart2Save) that designs ECG-based software for medical equipment. TM, PK, JL, MT, and HJ report personal fees from Heart2Save.
Figures



References
-
- Bashar S. K., Han D., Ding E., Whitcomb C., McManus D., Chon K. H. (2019). “Smartwatch based atrial fibrillation detection from Photoplethysmography signals,” in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, July 1, 2019. - PubMed
-
- Boriani G., Glotzer T. V., Santini M., West T. M., De Melis M., Sepsi M., et al. . (2014). Device-detected atrial fibrillation and risk for stroke: An analysis of >10,000 patients from the SOS AF project (stroke prevention strategies based on atrial fibrillation information from implanted devices). Eur. Heart J. 35, 508–516. doi: 10.1093/eurheartj/eht491, PMID: - DOI - PMC - PubMed
-
- Chen L. Y., Chung M. K., Allen L. A., Ezekowitz M., Furie K. L., McCabe P., et al. . (2018). American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council. Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association. Circulation 137, e623–e644. doi: 10.1161/CIR.0000000000000568, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials